Early total knee arthroplasty (TKA) designs used all-polyethylene tibial components with good success rates ([@CIT0020], [@CIT0022], [@CIT0013]). With metallurgical enhancements and polyethylene modifications, metal-backed tibial modularity was introduced onto the market. This enabled decisions regarding soft tissue tensioning to be made even after cementation of the final components. The added benefits of implant inventory reduction and improved polyethylene shelf-life, especially for rarely used sizes, further increased the universal adoption of tibial component modularity. However, micromotion of the modular junction between the polyethylene liner and the tibial base plate created a second interface for polyethylene wear debris production. A few studies have evaluated the role of micromotion and backside wear in the eventual development of osteolysis, and these have indicated that it increases the risk of revision ([@CIT0024], [@CIT0015]).

Clinically, the use of metal-backed TKAs has a high success rate at long-term follow-up ([@CIT0009], [@CIT0002], [@CIT0014]), but backside wear continues to be an issue that limits implant longevity. In contrast, as demonstrated by radiostereometric analysis (RSA) techniques, the monoblock all-polyethylene tibial component has less component migration and better tibial fixation than fixed, metal-backed designs ([@CIT0012], [@CIT0007], [@CIT0014]). This would theoretically decrease or eliminate backside wear and the possibility of eventual revision. Despite this factor and its economic value, the all-polyethylene tibial component has not been widely adopted.

Given the current demographic trends of younger patients seeking reconstructions and the activity-based demands placed on the arthroplasty construct ([@CIT0008]), consideration of the role that implant characteristics play in arthroplasty longevity is warranted. Using a community-based sample of primary TKAs, we compared the early risk of revision (all-cause and aseptic) of a monoblock all-polyethylene tibial component with that for a metal-backed modular tibial construct of the same articular geometry and from the same manufacturer, while adjusting for potential confounders.

Methods {#ss1}
=======

Study design, inclusion criteria, and data collection {#ss2}
-----------------------------------------------------

We conducted a retrospective analysis of a prospectively followed cohort of primary TKA patients using data from a community-based Total Joint Replacement Registry (TJRR). Patients with any diagnosis who underwent a primary fixed-bearing TKA from a single implant manufacturer (Depuy) were included in the sample. Cases were registered between April 1, 2001 and December 30, 2010. Data collection, participation, and coverage of the TJRR used to identify the cases and data have been published elsewhere ([@CIT0016], [@CIT0017] [@CIT0018], [@CIT0019]). Briefly, the TJRR uses a hybrid data collection process (paper and electronic) to capture patient characteristics together with implant and surgical information, and also validated algorithms to capture the outcomes of interest. Intraoperative information is collected by the surgeon at the time of the procedure. The TJRR sample included in the study covers 40 medical centers and 233 surgeons in 6 geographical regions of the USA (Southern and Northern California, Colorado, Hawaii, Northwest, and Mid-Atlantic). The voluntary participation of the registry in 2010 was 95% ([@CIT0019]).

Exposure of interest {#ss3}
--------------------

Implants were classified into metal-backed modular components or monoblock all-polyethylene tibial components using their catalog numbers and descriptions. Metal-backed components included Depuy's Press-Fit Condylar (PFC) and Sigma designs. The monoblock all-polyethylene design investigated was Depuy's PFC\*Sigma. In these implants, the surface geometry of the tibial liner includes concave portions to accept the femoral bearing surface, which are neither flat nor completely conforming. The surface geometries are identical in the all-polyethylene versions and the modular versions. All implants used during the TKA procedure are recorded using the implant stickers that accompany each implant package. These data are entered manually into the TJRR, and quarterly quality control is conducted to check for data-entry errors and inconsistencies.

Outcome of interest {#ss4}
-------------------

The endpoint was all-cause revision and aseptic revision. Revision was defined as any operation after the index TKA where a component was replaced. Aseptic revisions were revisions performed for any reason other than infection-related causes. Reasons for revision were recorded by the surgeons in the operative forms of the TJRR and confirmed with chart review by a trained clinical research associate.

Covariates {#ss5}
----------

Several covariates were investigated as possible confounders or effect modifiers of the association of tibial component design and the outcomes of interest. Covariates investigated included: patient characteristics (age, race, gender, BMI, diabetes status), primary TKA diagnosis (osteoarthritis, osteonecrosis, posttraumatic arthritis, or rheumatoid arthritis), ASA health status score, surgeons' total joint arthroplasty fellowship training status, surgeon and hospital average annual volume, implant stability (cruciate retaining vs. posterior stabilized), implant fixation (cemented, hybrid, or uncemented), patellar resurfacing, operative time, and whether or not the procedure was bilateral.

Statistics {#ss6}
----------

Frequencies, proportions, means, standard deviations (SDs), medians and interquartile ranges (IQRs) were used to describe the study sample. Comparisons between metal-backed modular and monoblock all-polyethylene tibial components used chi-square tests for categorical variables and Student t-tests for continuous variables. Crude revision rates and revision rate per 100 years of observation were calculated for all-cause revision and aseptic revision. Cox proportional hazard models for multivariable survival data (adjusted for surgeon clustering using a sandwich covariance matrix estimator) were used to assess hazard ratios (HRs) and 95% confidence intervals (CIs) for the type of tibial component and risk of all-cause and aseptic revision. Proportional hazard assumptions were evaluated using graphs of survival function against survival time. A model for the entire cohort was developed, as well as models for a younger age group (\< 65 years old) and an older one (≥ 65 years old). Covariates were explored as confounders of the associated of tibial component and risk of failure. Variables not confounding the association between tibial component type and risk of revision (changed estimates by \> 20%) were not included in the final models. The final models were adjusted for age and sex. To account for missing values of some variables, multiple imputations were performed to create 10 versions of the analytic data set and we then used Rubin's combining rules to calculate the final parameter estimates and CIs from the 10 output sets ([@CIT0021]). The imputation model used included all covariates, event indicator, and Nelson-Aalen estimator of the cumulative baseline hazard at the time of event or censoring for each case ([@CIT0010], [@CIT0025]). The data were analyzed using SAS software version 9.2 and α = 0.05 was used as the threshold for statistical significance.

Ethics {#ss7}
------

Internal Review Board (IRB \# 5488) approval was obtained before the study was started.

Results {#ss8}
=======

27,657 fixed primary TKAs were included in the study sample. The cohort had a higher percentage of women (63.7%), and the mean age was 68.4 (SD 9.1) years. The majority of patients had a diagnosis of osteoarthritis (97.2%) and were white (62.9%). Of the total, 2,306 (8.3%) had monoblock all-polyethylene tibial components and 25,351 (91.7%) had metal-backed modular components. No monoblock pre-molded composite tibial components were registered. During the study period, 5.4% (n = 1,501) of the cohort died and 8.2% (n = 2,264) were followed for a median time of 1.8 (IQR: 0.8--3.3) years before leaving the health plan and being categorized as lost to follow-up. Patients who were lost to follow-up were younger than those in the cohort (10% were \< 55 years of age as compared to 6% of those who remained in the study cohort) but no difference in sex distribution was observed. 12% (n = 272) of the 2,306 monoblock all-polyethylene tibial components and 8% (n = 1,992) of the 25,351 metal-backed modular components were implanted in patients who were lost to follow-up.

The cohort of patients who received monoblock all-polyethylene tibial components had a higher mean age (71.8 vs. 68.1 years, p \< 0.001), had a higher proportion of whites (72.7% vs. 62%, p \< 0.001), had lower mean BMI (30.1 vs. 31.6, p 0.001), and had a slightly different distribution of ASA scores in comparison to the cohort of patients with metal-backed modular tibial components ([Table 1](#T1){ref-type="table"}).

###### 

Study sample characteristics by component modularity, 2001--2010

  ------------------------------------------------------------------------------------------------------------
                            Total sample   Metal-backed\   Monoblock\                               
                                           modular         all-polyethylene                         
  ------------------------- -------------- --------------- ------------------ ------ ------- ------ ----------
  No.                       27,657         100             25,351             91.7   2,306   8.3    

  Mean age, years           68.4           9.1             68.1               9.1    71.8    9.0    \< 0.001

  Age category, years                                                                               

   \< 65                    9,215          33.3            8,737              34.8   478     20.7   \< 0.001

   ≥ 65                     18,439         66.7            16,611             65.5   1,828   79.3   

  Sex                                                                                               

   Female                   17,614         63.7            16,170             63.8   1,444   62.6   0.3

   Male                     10,042         36.3            9,180              36.2   862     37.4   

  Race                                                                                              

   White                    17,393         62.9            15,716             62.0   1,677   72.7   \< 0.001

   Hispanic                 4,516          16.3            4,206              16.6   310     13.4   

   Black                    2,154          7.8             2,087              8.2    67      2.9    

   Asian                    1,407          5.1             1,314              5.2    93      4.0    

   Other/Multi              541            2.0             510                2.0    31      1.3    

   Unknown                  1,646          6.0             1,518              6.0    128     5.6    

  Diabetes                  7,658          27.7            7,017              27.7   641     27.8   0.9

  Mean BMI (mean, SD)       31.4           6.2             31.6               6.3    30.1    5.4    \< 0.001

   Unknown                  515            1.9             463                1.8    52      2.3    

  ASA score                                                                                         

   1 & 2                    15,861         57.4            14,493             57.2   1,368   59.3   0.003

   ≥ 3                      11,224         40.6            10,314             40.7   910     39.5   

   Unknown                  572            2.1             544                2.2    28      1.2    

  Osteoarthritis            26,880         97.2            24,630             97.2   2,250   97.6   0.2

  Osteonecrosis             137            0.5             123                0.5    14      0.6    0.4

  Posttraumatic arthritis   250            0.9             237                0.9    13      0.6    0.07

  Rheumatoid arthritis      579            2.1             530                2.1    49      2.1    0.91
  ------------------------------------------------------------------------------------------------------------

Missing data: age (n = 3, 0.1%), sex (n = 1, 0.0%).

There was a difference in the proportion of cases operated by surgeons with fellowship training (37.5% in the monoblock all-polyethylene cohort and 42.5% in the metal-backed modular cohort; p \< 0.001). A higher proportion of monoblock all-polyethylene components were used by surgeons with high annual volumes (70.4% vs. 60.6%, p \< 0.001). All arthroplasties using a monoblock all-polyethylene component were performed in hospitals with high annual volumes (100% vs. 84.6%, p \< 0.001). A higher proportion of monoblock all-polyethylene components than metal-backed modular components were posterior stabilized constructs (77.8% vs. 64.8%, p \< 0.001). In addition, a higher proportion of metal-backed cases than monoblock cases were performed without a patellar resurface (2.4% vs. 1.2%, p \< 0.001). Cases with monoblock all-polyethylene tibial components had a shorter operative time than those with metal-back modular components (87.4 vs. 92.7 min, p \< 0.001) ([Table 2](#T2){ref-type="table"}).

###### 

Surgeon, hospital, procedure, and implant characteristics according to component modularity, 2001--2010

  ----------------------------------------------------------------------------------------------------------------------
                                     Total sample   Metal-backed\   Monoblock\                                
                                                    modular         all-polyethylene                          
  ---------------------------------- -------------- --------------- ------------------ ------- ------- ------ ----------
  Total no.                          27,657         100             25,351             91.7    2,306   8.3    

  Fellowship training                11,644         42.1            10,780             42.5    864     37.5   \< 0.001

  Surgeon, average annual volume                                                                              

   \< 20                             1,639          5.9             1,613              6.4     26      1.1    \< 0.001

   20--49                            9,031          32.7            8,375              33.0    656     28.5   

   ≥ 50                              16,987         61.4            15,363             60.6    1,624   70.4   

  Hospitals                          40             100.0           40                 100.0   13      32.5   

  Hospital, average yearly volume                                                                             

   \< 100                            558            2.0             558                2.2     0       0.0    \< 0.001

   100--199                          3,358          12.1            3,358              13.3    0       0.0    

   ≥ 200                             23,741         85.8            21,435             84.6    2,306   100    

  Implant stability                                                                                           

   CR                                9,408          34.0            8,897              35.1    511     22.2   \< 0.001

   PS                                18,223         65.9            16,430             64.8    1,793   77.8   

   Unknown                           26             0.1             24                 0.1     2       0.1    

  Fixation                                                                                                    

   Cemented                          24,987         90.4            22,810             90      2,177   94.4   \< 0.001

   Hybrid                            1,267          4.6             1,244              4.9     23      1.0    

   Uncemented                        114            0.4             106                0.4     8       0.4    

   Unknown                           1,289          4.7             1,191              4.7     98      4.3    

  Patella not resurfaced             631            2.3             603                2.4     28      1.2    \< 0.001

  Bilateral procedures               2,821          10.2            2,587              10.2    234     10.2   0.9

  Operative time (min), (mean, SD)   92.3           32.4            92.7               32.7    87.4    28.4   \< 0.001
  ----------------------------------------------------------------------------------------------------------------------

CR: cruciate retaining; PS: posterior stabilized.

The crude all-cause revision rate for the overall cohort was 2.07%. The cohort was followed for a median time of 2.9 (IQR: 1.2--5.1) years. The rate was lower for monoblock all-polyethylene components than for metal-backed modular components (0.95% vs. 2.17%, p \< 0.001). The incidence rate of revision per 100 years of observation for all-cause revision of the monoblock all-polyethylene components was 0.30, and for the metal-backed modular components it was 0.65. For aseptic revisions, this incidence rate was also lower for the monoblock all-polyethylene cohort (0.18 vs. 0.35) ([Table 3](#T3){ref-type="table"}).

###### 

Crude revision rate and revision rate/100 years of observation for all-cause revision and aseptic revision, for the overall cohort and according to component modularity

  ----------------------------------------------------------------------------------------------------------------------
                        Total sample   Metal-backed\   Monoblock\         p-value                             
                                       modular         all-polyethylene                                       
  --------------------- -------------- --------------- ------------------ ------------ --------- ------------ ----------
  Crude revision rate   n              (%)             n                  (%)          n         (%)          

   All-cause            572            2.07            550                2.17         22        0.95         \< 0.001

   Aseptic              313            1.13            300                1.18         13        0.56         0.007

  Revision rate/100 y                                                                                         

   of observation       Total y        Rate/100 y      Total y            Rate/100 y   Total y   Rate/100 y   

   All-cause            92,273         0.62            84,971             0.65         7,302     0.30         

   Aseptic                             0.34                               0.35                   0.18         
  ----------------------------------------------------------------------------------------------------------------------

After adjusting for age and sex (no other variables were found to be confounders), in the all-cause revision models, the early risk of revision associated with using a monoblock all-polyethylene tibial component was 0.51 (CI: 0.33--0.78) times the risk of revision with a metal-backed modular component. In the age-specific analysis, in younger patients (\< 65 years old), the all-cause risk of revision for a monoblock all-polyethylene component was 0.26 (CI: 0.10--0.72) times lower than that for a metal-backed modular component. In the older group (≥ 65 years old), the risk of early revision was also lower with the monoblock all-polyethelene components (HR = 0.59, CI: 0.35--0.99). In aseptic revision models, monoblock all-polyethylene components were associated with a lower risk of early revision than metal-backed modular components only in the younger age-specific model (HR = 0.27, CI: 0.11--0.65) ([Table 4](#T4){ref-type="table"}).

###### 

Adjusted risk of all-cause and aseptic revision for all-polyethylene monoblocks compared to metal-backed modular tibial components. Cox proportional hazard models

                              HR     95% CI       p-value
  --------------------------- ------ ------------ ---------
  All-cause revision models                       
   Overall                    0.51   0.33--0.78   0.002
   Patients ≥ 65 years old    0.59   0.35--0.99   0.05
   Patients \< 65 years old   0.26   0.10--0.72   0.01
  Aseptic revision models                         
   Overall                    0.59   0.29--1.19   0.1
   Patients ≥ 65 years old    0.75   0.32--1.76   0.5
   Patients \< 65 years old   0.27   0.11--0.65   0.003

Discussion {#ss9}
==========

With 2.9 years of median follow-up, the fixed monoblock all-polyethylene tibial component was identified as a superior construct for TKA. For arthroplasties performed with a monoblock all-polyethylene tibial component, the all-cause revision rate per 100 years of observation was 0.30. During the same period, for arthroplasties performed with a metal-backed modular tibial component, the crude revision rate per 100 years of observation was 0.65. Based on adjusted models, the use of a monoblock all-polyethylene component was associated with a 50% lower risk of early revision. In younger patients (\< 65 years old), the lower risk of early revision associated with monoblock all-polyethylene components was even more pronounced, as it was approximately 74% lower than that for metal-backed modular components.

Most studies have not found any statistically or clinically significant difference in the risk of revision between arthroplasties performed with either a metal-backed tibial component or a monoblock all-polyethylene tibial component ([@CIT0006], [@CIT0003], [@CIT0004], [@CIT0023]). In a meta-analysis of 9 randomized controlled trials published between 2000 and 2009 using 5 different implant systems, [@CIT0004] reported similar clinical results between the 2 groups in terms of knee scores, quality of life, range of motion, radiographic implant alignment, and postoperative complications. In their analysis, they did not find that metal-backed tibial components were superior to the monoblock all-polyethylene tibial construct. Another meta-analysis of 12 studies and 1,798 implants found that the lower-cost monoblock all-polyethylene component had clinical and functional results equivalent to the more expensive fixed metal-backed modular component ([@CIT0023]). [@CIT0023] also reported that there were no statistically significant differences in implant longevity at 2, 10, and 15 years postoperatively. In a prospective randomized controlled trial, [@CIT0003] reported 10-year survivorships of 97.0% for 304 metal-backed arthroplasties and 96.8% for 262 monoblock all-polyethylene implants. [@CIT0006] conducted a randomized study and reported a 10-year survivorship of 92% for 97 monoblock all-polyethylene tibial components with revision for any reason and 100% for aseptic loosening. In their study, the survivorship of 70 metal-backed modular components was 89% with revision for any reason and 94% for aseptic loosening. In a case-series study, also by [@CIT0005], the reported 14-year survivorship of the all-polyethylene cases entered in the institutional registry was 99% comparable with their clinical trial results. In our cohort, however, we found a statistically and clinically significant difference between these 2 tibial constructs. There may be several reasons for the differences between our findings and those published in the literature. Firstly, the previously published studies may have been underpowered. Secondly, from a patient and surgeon point of view, our study sample was diverse, thus allowing us to measure the real-world performance of these constructs. Finally, the follow-up periods of published studies varied from 2 to 10 years, whereas our median follow-up was 2.9 years.

Additional reports on the topic include annual reports from national total joint arthroplasty registries (National Joint Registry for England and Wales 2010, AOA 2011). In the Eighth Annual Report of the National Joint Registry for England and Wales (NJREW), the revision rate at 7 years for all bicondylar knees (n = 313,069) was 3.9% (National Joint Registry for England and Wales 2010). In that same time period, 3.7% of the 43,708 monoblock tibias were revised. In the NJREW report, no distinction was made between monoblock all-polyethylene tibial components and pre-assembled metal-polyethylene monoblock tibial components, but a slightly lower 7-year revision rate was seen for monoblock tibial constructs. In contrast, the 2012 Report of the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) categorized monoblock tibias into monoblock all-polyethylene components and molded non-modular components ([@CIT0001]). The incidence rate of revision per 100 years of observation was highest with the monoblock all-polyethylene component (0.74) and lowest with the molded non-modular component (0.58). In comparison, the metal-backed modular revision rate per 100 years of observation was 0.67. The cumulative revision rate at 10 years was 5.1% for the meta-backed modular components, 5.4% for the monoblock all-polyethylene components, and 4.7% for the molded non-modular components. The different lengths of follow-up in the different cohorts and the implant selection criteria are 2 observations of importance, and possibly explain the observed differences when comparing our data to those from the AOANJRR cohort.

The limitations of our investigation were related to the study design, the retrospective nature of the study, and follow-up. However, the outcomes were prospectively ascertained and adjudicated by a trained research coordinator to reduce the possibility of informational bias. It is possible that selection bias may have existed in our sample. In our analysis, we tried to adjust for the variables we found to be confounders of the association between implant choice and risk of revision. However, there may still be certain patient-specific or implant-based characteristics that we have not been able to account for that may have influenced surgical and clinical decision-making. The definition of failure was surgical revision, which does not account for patient function and satisfaction as a measure of success of arthroplasty. Radiographically failing arthroplasties were not accounted for in our study. However, we have no reason to believe that there would be a differential rate of radiographically defined failures between the study groups, and if there was under-ascertainment of failures, this was probably non-differential.

The purposeful restriction of our analysis to a single implant (PFC Sigma) manufactured by the same company (DePuy) with the same articular geometry in both the metal-backed modular component and the monoblock all-polyethylene component allowed us to focus on the role of tibial modularity in arthroplasty survival. This strategy increased the internal validity of our measurements as they applied to Depuy components, but our results may not be generalizable to monoblock all-polyethylene components from other manufacturers with possibly different design features.

Our loss to follow-up, another limitation, was slightly higher in the monoblock all-polyethylene group (12%) than in the metal-backed modular group (8%). It is unlikely that such a small difference between the cohorts would cause our estimations to be biased to the degree presented here. In addition, the "lost to follow-up" cohort contributed a median of 1.8 years of observation before attrition, thereby contributing to a substantial amount of the follow-up period (in which they did not have a revision). Those lost to follow-up were also younger than the patients who were not lost to follow-up, supporting the idea that if the effects we are seeing are even greater in a younger population, they must not be overestimated since that would be the group most likely to miss event ascertainment. In addition, these are short-term follow-up risk estimations and the results should be interpreted as such. Our conclusions are fit for the follow-up time of our cohort, and we hope that once longer follow-up is available in this study cohort, we will be able to re-evaluate this patient sample.

The strengths of the present study include its large sample size, the diversity of the patient and surgeon sample included, and the internal validity of the TJRR used for the study. Our sample size allowed us not only to evaluate the relationship between implant modularity and outcomes of TKA, but also to evaluate models stratified by age and adjust our analysis for possible confounders of the relationship studied. In addition, the diversity of the sample included in our study (inclusive of non-Medicare aged groups and inclusive of various racial groups) increases the generalizability of our findings to various patient populations. Similarly, the number of surgeons and medical centers that contributed to this study, with several levels of skill, volume, and training, as well as different medical center characteristics increase the external validity of our findings, which we believe are applicable to a range of surgeons and medical centers. Finally, the TJRR collects prospective information on all the registered TKA cases and uses validated algorithms to ascertain the events evaluated in this study. It also adjudicates every outcome via chart review. This mechanism of event ascertainment together with the integrated linkage to healthcare systems and access to patient activity increases the internal validity of the information we are reporting, as information bias is probably minimized.

Conclusion {#ss10}
----------

An analysis of primary TKAs registered in a community-based TJRR showed that in monoblock all-polyethylene tibial components, the risk of revision was approximately 49% (CI: 22--67%) lower in the 2.9 years of median follow-up of our cohort than in patients with metal-backed modular components. For younger patients (\< 65 years old), the risk of revision was even lower for the monoblock all-polyethylene component, where the hazard ratio was approximately 0.3 (CI: 0.1--0.7) times that for the metal-backed modular component.
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